Home » Topics » Regulatory

Regulatory
RSS

Mucosta approved in Japan for dry eye syndrome

Sep. 27, 2011

FDA approves new indication for Soliris

Sep. 27, 2011

Japanese authorities extend indication of Venogloblulin

Sep. 27, 2011

Asahi Kasei Pharma clear to market osteoporosis therapy in Japan

Sep. 27, 2011

Remicade approved in U.S. for new indication

Sep. 26, 2011

Avastin approved for new indication in Japan

Sep. 26, 2011

European approval of Removab broadened

Sep. 21, 2011

FDA approves Prolia for new indications

Sep. 20, 2011

Ono Pharmaceutical secures new Japanese approval for Glactiv

Sep. 19, 2011

Vibativ approved in Europe

Sep. 15, 2011

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...